col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


33 Ergebisse       Seite 1

 [1] 
Oxford University Press: Biology Methods and Protocols
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2024―Nov―27 Development of a large-scale rapid LAMP diagnostic testing platform for pandemic preparedness and outbreak response Rinie van Beuningen, Kin Ki Jim, Maikel Boot, Michel Ossendrijver, Bart J F Keijser, Jeroen H B van de Bovenkamp, et al. (+2)
2 [GO] 2024―Nov―27 iHDSel software: The price equation and the population stability index to detect genomic patterns compatible with selective sweeps. An example with SARS-CoV-2 Antonio Carvajal-Rodríguez
3 [GO] 2024―Sep―23 Optimization and Application of Digital Droplet PCR for the Detection of SARS-CoV-2 in Saliva Specimen Using Commercially Available Kit Maria Mardalena Martini Kaisar, Helen Kristin, Fajar Ade Wijaya, Clarissa Rachel, Felicia Anggraini, Soegianto Ali
4 [GO] 2024―Jun―21 KCL TEST: an open-source inspired asymptomatic SARS-CoV-2 surveillance programme in an academic institution Joana Reis de Andrade, Edward Scourfield, Shilpa Lekhraj Peswani-Sajnani, Kate Poulton, Thomas Ap Rees, Paniz Khooshemehri, et al. (+33)
5 [GO] 2024―Mai―22 A One-Step Low-Cost molecular test for SARS-CoV-2 detection suitable for community testing using minimally processed saliva Sofia M da Silva, Catarina Amaral, Cláudia Malta-Luís, Diana Grilo, Américo G Duarte, Inês Morais, et al. (+8)
6 [GO] 2024―Apr―25 Detection of SARS-CoV-2 B.1.1.529 (omicron) variant by SYBR green-based RT-qPCR Fadi Abdel-Sater, Rawan Makki, Alia Khalil, Nader Hussein, Nada Borghol, Ziad Abi Khattar, et al. (+14)
7 [GO] 2024―Jan―23 Baricitinib statistically significantly reduced COVID-19-related mortality: a systematic review and meta-analysis of five phase III randomized, blinded and placebo-controlled clinical trials Sivananthan Manoharan, Lee Ying Ying
8 [GO] 2024―Jan―16 tANCHOR cell-based ELISA approach as a surrogate for antigen-coated plates to monitor specific IgG directed to the SARS-CoV-2 receptor binding domain Hubert Bernauer, Josef Maier, Norbert Bannert, Daniel Ivanusic
9 [GO] 2023―Dez―12 tANCHOR fast and cost-effective cell-based immunization approach with focus on the receptor-binding domain of SARS-CoV-2 Hubert Bernauer, Anja Schlör, Josef Maier, Norbert Bannert, Katja Hanack, Daniel Ivanusic
10 [GO] 2023―Dez―05 COVID's long shadow: How SARS-CoV-2 infection, COVID-19 severity, and vaccination status affect long-term cognitive performance and health Jaroslav Flegr, Ashkan Latifi
11 [GO] 2023―Nov―14 Crowdsourcing Temporal Transcriptomic Coronavirus Host Infection Data: resources, guide, and novel insights James Flynn, Mehdi M Ahmadi, Chase T McFarland, Michael D Kubal, Mark A Taylor, Zhang Cheng, et al. (+2)
12 [GO] 2023―Okt―18 The Effect of the COVID-19 Pandemic on Life Expectancy in the US: An Application of Hybrid Life Expectancy Warren C Sanderson, Sergei Scherbov
13 [GO] 2023―Sep―27 De novo design of anti-variant COVID-19 vaccine Arpita Goswami, Madan Kumar, Samee Ullah, Milind M Gore
14 [GO] 2023―Aug―22 SARS-CoV-2 sublingual vaccine with RBD antigen and poly(I:C) adjuvant: Preclinical study in cynomolgus macaques Tetsuro Yamamoto, Masanori Tanji, Fusako Mitsunaga, Shin Nakamura
15 [GO] 2023―Jul―25 Exposing and exploiting host-parasite arms race clues in SARS-CoV-2: a principally new method for improved T cell immunogenicity prediction Jaroslav Flegr, Ivana Králová Lesná, Daniel Zahradník
16 [GO] 2023―Jun―08 “Clinical validation of 3D-printed swabs in adults and children for SARS-CoV-2 detection” Sanchez-Sandoval Ana Laura, Sánchez-Pérez Celia, García-García José Antonio, Uriega-González Plata Silvia, Guerrero-Avendaño Guadalupe Mercedes Lucía, Barrón-Palma Eira Valeria
17 [GO] 2023―Feb―14 Biophysical characterisation of the structure of a SARS-CoV-2 self-amplifying-RNA (saRNA) vaccine Daniel P Myatt, Lewis Wharram, Charlotte Graham, John Liddell, Harvey Branton, Claire Pizzey, et al. (+3)
18 [GO] 2023―Jan―17 Executive protocol designed for new review study called: systematic review and artificial intelligence network meta-analysis (RAIN) with the first application for COVID-19 Nader Salari, Shamarina Shohaimi, Aliakbar Kiaei, Amin Hosseinian-Far, Kamran Mansouri, Arash Ahmadi, Masoud Mohammadi
19 [GO] 2022―Dez―15 The effects of 105 biological, socioeconomic, behavioral, and environmental factors on the risk of SARS-CoV-2 infection and a severe course of COVID-19: a prospective, explorative cohort study Jaroslav Flegr, Pavel Flegr, Lenka Příplatová
20 [GO] 2022―Dez―14 Improved prediction of new COVID-19 cases using a simple vector autoregressive model: Evidence from seven New York State counties Takayoshi Kitaoka, Harutaka Takahashi
21 [GO] 2022―Nov―21 The COVID-19 Community Research Partnership; A multistate surveillance platform for characterizing the epidemiology of the SARS-CoV-2 pandemic John W Sanders, Thomas F Wierzba, John Walton Sanders, David Herrington, Mark A Espeland, John Williamson, et al. (+225)
22 [GO] 2022―Nov―10 An ensemble prediction model for COVID-19 mortality risk Jie Li, Xin Li, John Hutchinson, Mohammad Asad, Yinghui Liu, Yadong Wang, Edwin Wang
23 [GO] 2022―Nov―01 Molecular markers for early stratification of disease severity and progression in COVID-19 Anusha Kashyap, Savitha Anne Sebastian, Raksha N, Raksha K, Krishnamurthy H, Bhuvana Krishna, et al. (+3)
24 [GO] 2022―Okt―29 HAT-field: a cheap, robust and quantitative point-of-care serological test for covid-19 Etienne Joly, Agnès Maurel Ribes
25 [GO] 2022―Okt―29 All-cause and In-hospital Mortality after Aspirin Use in Patients Hospitalized with COVID-19: A Systematic Review and Meta-analysis Nischit Baral, Joshua D Mitchell, Pramod K Savarapu, Maxwell Akanbi, Bandana Acharya, Soumya Kambalapalli, et al. (+7)
26 [GO] 2022―Sep―19 Novel deterministic epidemic model considering mass vaccination and lockdown against coronavirus disease 2019 spread in Israel: A numerical study Motoaki Utamura, Makoto Koizumi, Seiichi Kirikami
27 [GO] 2022―Sep―01 SPARSEMODr: Rapidly simulate spatially-explicit and stochastic models of COVID-19 and other infectious diseases Joseph R Mihaljevic, Seth Borkovec, Saikanth Ratnavale, Toby D Hocking, Kelsey E Banister, Joseph E Eppinger, et al. (+2)
28 [GO] 2022―Aug―25 STArS (STrain-Amplicon-Seq), a targeted Nanopore sequencing workflow for SARS-CoV-2 diagnostics and genotyping Simone Maestri, Valentina Grosso, Massimiliano Alfano, Denise Lavezzari, Chiara Piubelli, Zeno Bisoffi, et al. (+2)
29 [GO] 2022―Aug―22 Sera of patients infected by earlier lineages of SARS-CoV-2 are capable to neutralize later emerged variants of concern Alex Pauvolid-Corrêa, Braulia Costa Caetano, Ana Beatriz Machado, Mia Araújo Ferreira, Natalia Valente, Thayssa Keren Neves, et al. (+6)
30 [GO] 2022―Aug―04 A Novel Method for Handling Pre-Existing Conditions in Multivariate Prediction Model Development for COVID-19 Death Heather M Campbell, Allison E Murata, Jenny T Mao, Benjamin McMahon, Glen H Murata
31 [GO] 2022―Mai―31 MLBioIGE: Integration and Interplay of Machine Learning and Bioinformatics Approach to Identify the Genetic Effect of SARS-COV-2 on Idiopathic Pulmonary Fibrosis Patients Sk. Tanzir Mehedi, Kawsar Ahmed, Francis M Bui, Musfikur Rahaman, Imran Hossain, Tareq Mahmud Tonmoy, et al. (+3)
32 [GO] 2020―Aug―19 Easing diagnosis and pushing the detection limits of SARS-CoV-2 Uday Kiran, C G Gokulan, Santosh Kumar Kuncha, Dhiviya Vedagiri, Bingi Thrilok Chander, Aedula Vinaya Sekhar, et al. (+5)
33 [GO] 2020―Jul―16 Rapid and Inexpensive Whole-Genome Sequencing of SARS-CoV-2 using 1200 bp Tiled Amplicons and Oxford Nanopore Rapid Barcoding Nikki E Freed, Markéta Vlková, Muhammad B Faisal, Olin K Silander
 [1] 

33 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.003 sec